NextGen Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
NextGen Healthcare Stock Forecast and Price Target
The average target price set lately by experts for NextGen Healthcare to reach by the end of the year is $10.33, which would imply a potential downside of approximately -56.85 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $11.57 and a low estimate of $9.19. If interested in NXGN stock, you may also want to consider its competitors.
-56.85% Downside
NextGen Healthcare Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, NextGen Healthcare's Price has grown by 18.07%, rising from $15.45 to $18.24. For next year, analysts predict Fair Value of $24.57, which would mean an increase of 34.69%. Over the next nine years, experts predict that NextGen Healthcare's Fair Value will grow at a rate of 168.37%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ORCL Stock Forecast | Oracle Corp | Outperform |
13
|
$116.00 | Buy/Sell | $124.26 | 24.14% |
| INTU Stock Forecast | Intuit Inc | Outperform |
11
|
$608.38 | Buy/Sell | $678.62 | 18.35% |
| IBM Stock Forecast | International Business Machine... | Hold |
7
|
$181.47 | Buy/Sell | $175.67 | 4.70% |
| FI Stock Forecast | Fiserv | Outperform |
10
|
$146.91 | Buy/Sell | $150.93 | 11.97% |
| WDAY Stock Forecast | Workday | Outperform |
16
|
$255.64 | Buy/Sell | $257.26 | 27.13% |
NextGen Healthcare Revenue Forecast for 2023 - 2025 - 2030
In the last three years, NextGen Healthcare's Revenue has grown by 20.90%, rising from $540.24M to $653.17M. For next year, analysts predict Revenue of $770.25M, which would mean an increase of 17.92%. Over the next nine years, experts predict that NextGen Healthcare's Revenue will grow at a rate of 67.05%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IQV Stock Forecast | IQVIA Holdings | Outperform |
15
|
$227.17 | Buy/Sell | $267.27 | 21.05% |
| FIS Stock Forecast | Fidelity National Information ... | Outperform |
17
|
$70.00 | Buy/Sell | $69.28 | 7.86% |
| BR Stock Forecast | Broadridge Financial Solutions | Hold |
18
|
$192.98 | Buy/Sell | $208.09 | 8.82% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SSNC Stock Forecast | SS&C Technologies Holdings | Outperform |
18
|
$60.47 | Buy/Sell | $70.57 | 17.41% |
| SGE Stock Forecast | The Sage Group | Hold |
18
|
£11.45 | Buy/Sell | £11.01 | 9.17% |
| LOGN Stock Forecast | Logitech International | Hold |
18
|
CHF71.84 | Buy/Sell | CHF73.92 | 17.64% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JKHY Stock Forecast | Jack Henry & Associates Inc | Outperform |
16
|
$164.77 | Buy/Sell | $172.00 | 8.94% |
| HSIC Stock Forecast | Henry Schein | Hold |
7
|
$69.97 | Buy/Sell | $75.16 | 16.05% |
| RCM Stock Forecast | R1 RCM | Outperform |
14
|
$12.02 | Buy/Sell | $18.09 | 37.27% |
NextGen Healthcare EBITDA Forecast for 2023 - 2025 - 2030
NextGen Healthcare's EBITDA has grown In the last three years, rising from $31.55M to $48.04M – a growth of 52.27%. In the next year, analysts believe that EBITDA will reach $149.58M – an increase of 211.37%. For the next ten years, experts predict that NextGen Healthcare's EBITDA will grow at a rate of 459.12%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EVH Stock Forecast | Evolent Health | Outperform |
9
|
$29.62 | Buy/Sell | $44.92 | 51.92% |
| ACIW Stock Forecast | ACI Worldwide | Buy |
16
|
$31.51 | Buy/Sell | $33.40 | 20.60% |
| SOW Stock Forecast | Software | - |
18
|
35.45€ | Buy/Sell | 29.61€ | -100.00% |
NextGen Healthcare EBIT Forecast for 2023 - 2025 - 2030
NextGen Healthcare's EBIT has seen impressive growth In the last three years, rising from $19.24M to $39.07M – a growth of 103.07%. In the next year, analysts believe that EBIT will reach $117.45M – an increase of 200.61%. For the next ten years, the forecast is for EBIT to grow by 478.70%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PHR Stock Forecast | Phreesia | Buy |
6
|
$22.62 | Buy/Sell | $27.40 | 32.63% |
| MDRX Stock Forecast | Veradigm | Outperform |
13
|
$7.55 | Buy/Sell | $16.33 | 58.94% |
| HSTM Stock Forecast | HealthStream | Outperform |
16
|
$23.99 | Buy/Sell | $31.67 | 33.39% |
NextGen Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, NextGen Healthcare's EPS has grown by 18.07%, rising from $0.83 to $0.98. For next year, analysts predict EPS of $1.32, which would mean an increase of 34.69%. Over the next nine years, experts predict that NextGen Healthcare's EPS will grow at a rate of 168.37%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FI Stock Forecast | Frank's International N.V. | - |
6
|
$11.50 | Buy/Sell | $30.00 | -100.00% |
| HCAT Stock Forecast | Health Catalyst | Outperform |
7
|
$5.70 | Buy/Sell | $11.92 | 101.75% |
| OPRX Stock Forecast | OptimizeRx | Outperform |
11
|
$9.35 | Buy/Sell | $15.20 | 71.12% |
.jpg)